Target intelligence / Profile preview

Metallothionein 1J, pseudogene (MT1JP)

Target: MT1JP
Molecular classification: Other

Overview

Metallothionein 1J, pseudogene (MT1JP) is a member of the metallothionein pseudogene family in humans. Unlike protein-coding metallothionein genes, MT1JP is classified as a pseudogene, meaning it does not encode a functional protein product[2][3]. There are multiple metallothionein 1 family members, and some are functional in metal ion homeostasis, detoxification, and oxidative stress, with established relevance in areas such as immune regulation and cancer biology[2][4]. However, MT1JP specifically is not a protein-coding gene and thus is not considered a therapeutic target or receptor, nor does it have well-established biological or disease functions, therapeutic agents, or biomarker utility.

Other names: MT1MT1JMT1NPMT1JPMTB

Beyond the preview

Go deeper on Metallothionein 1J, pseudogene (MT1JP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metallothionein 1J, pseudogene (MT1JP).

Explore the full profile